MARKET

ALVO

ALVO

Alvotech
NASDAQ
5.75
-0.13
-2.21%
After Hours: 5.75 0 0.00% 19:30 09/25 EDT
OPEN
5.90
PREV CLOSE
5.88
HIGH
5.90
LOW
5.67
VOLUME
705.19K
TURNOVER
--
52 WEEK HIGH
9.25
52 WEEK LOW
2.940
MARKET CAP
2.05B
P/E (TTM)
-9.1444
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALVO last week (0914-0918)?
Weekly Report · 6d ago
Why This Biotech Stock Just Got a Rare Double Upgrade
Barron‘s · 09/16 16:24
Midday Fly By: Stocks halt slide ahead of Fed
TipRanks · 09/16 16:06
Alvotech wins double upgrade at Barclays on upcoming FDA decision
Seeking Alpha · 09/16 14:02
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
Benzinga · 09/16 13:57
Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 09/16 13:10
Video: Intel up on reported memory chip manufacturing talks with SK Hynix
TipRanks · 09/16 13:05
Morning Movers: Intel, SK Hynix up after report on memory chip talks
TipRanks · 09/16 13:00
More
About ALVO
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVO stock methods without spending real money on the virtual paper trading platform.